biogem

Upcoming Events

What: Applications of Whole Human Genome Sequencing

When: Thursday, October 20, 2011 12:00 - 3:30 pm
Where: Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) Auditorium

San Diego Agenda

General Info

Registration

Announcements

(9/12/2011) HTS Sequencing Upgrades at BIOGEM
(9/12/2011) Biogem Capabilities

Welcome to the homepage of BIOGEM, at the University of California, San Diego.

The Biomedical Genomics laboratory (BIOGEM) is a genomics facility located in the Department of Medicine at UCSD. (BIOGEM) was established in 2000 to provide spotted cDNA microarray technology to the UCSD research community. Since then the scope has been expanded to include a variety of related services and resources, including several commercial microarray platforms and second (next-gen) generation sequencing technology. Currently BIOGEM provides RNA sample analysis and quantification services. Additionally BIOGEM processes commercial array platforms including Illumina and Agilent. Presently BIOGEM has 2 Illumina HiSeq2000 instruments and an Illumina GA2X instrument and supports a variety of sequencing assays including DNA-sequencing, digital gene expression, small RNA sequencing, chIP-sequencing and bisulfite sequencing.

BIOGEM also provides image scanning and data analysis services.

Microarray and next-gen sequencing experimentation, data acquisition and analysis require expensive instrumentation and reagents and a highly skilled team of individuals who are experts in specific components of the overall procedure. These technologies therefore lie beyond the scope of most individual laboratories and can only be made accessible to academic investigators through common core facilities. In addition to providing conventional genomic services, such cores provide essential platforms for advancing new technologies.

The Biomedical Genomics (BIOGEM) Core facility at UCSD has been instrumental in providing UCSD investigators access to these technologies. In particular, they have played a key role in enabling UCSD faculty to effectively compete for extramural grant support. The value of these technologies in discovery research has enabled investigators to identify signal transduction pathways, uncover new targets for therapeutic intervention, and reveal biomarkers for disease detection, prognosis, and guide treatment decision-making.

BIOGEM currently offers a range of microarray,sequencing and data analysis services to the local and international academic and biotech communities. Please contact Dr. Gary Hardiman <ghardiman@ucsd.edu> for more details.

For Affymetrix and Nimblegen Chips and Roche 454 sequencing, investigators should contact the GeneChip Microarray Core.
For Applied Biosystems TaqMan quantitative real-time PCR (qRT-PCR), investigators should contact the CFAR genomics core.

Gary Hardiman Ph.D.
Director BIOGEM

For more information on Dr. Hardiman's research and teaching activities please click here

Search the site with Google

Last Updated February 2012
By Dr. Gary Hardiman